
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.24 | 2.15 | 0.91 |
Stocks | 98.75 | 98.78 | 0.03 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.65 | 20.41 |
Price to Book | 4.08 | 4.04 |
Price to Sales | 2.23 | 2.45 |
Price to Cash Flow | 15.33 | 16.33 |
Dividend Yield | 1.94 | 1.37 |
5 Years Earnings Growth | 9.40 | 12.02 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.59 | 94.85 |
Basic Materials | 0.33 | 1.38 |
Consumer Defensive | 0.05 | 3.35 |
Financial Services | 0.02 | 8.94 |
Number of long holdings: 185
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.51 | 743.17 | -1.85% | |
UnitedHealth | US91324P1021 | 6.47 | 592.42 | +1.51% | |
J&J | US4781601046 | 4.80 | 154.71 | +0.71% | |
AbbVie | US00287Y1091 | 4.32 | 173.01 | -2.15% | |
Novo Nordisk B | DK0062498333 | 3.68 | 421.3 | -1.03% | |
Merck&Co | US58933Y1055 | 3.47 | 77.59 | -1.02% | |
Roche Holding Participation | CH0012032048 | 2.79 | 254.40 | -0.39% | |
Thermo Fisher Scientific | US8835561023 | 2.75 | 440.88 | -0.03% | |
Novartis | CH0012005267 | 2.71 | 90.46 | +0.29% | |
Abbott Labs | US0028241000 | 2.70 | 133.10 | +5.45% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust C Acc | 3.19B | 4.50 | 15.58 | 15.55 | ||
Legal General US Index Trust C Dist | 741.44M | 4.51 | 15.59 | 15.55 | ||
Legal General US Index Trust I Acc | 1.44B | 27.16 | 11.15 | 15.07 | ||
Legal General US Index Trust I Dist | 1.53B | 27.16 | 11.15 | 15.07 | ||
Legal General US Index Trust F Acc | 489.49K | -9.59 | 7.85 | 12.97 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review